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Abstract Type 2 diabetes (T2D) is a global health problem
showing substantial ethnic disparity in disease prevalence.
African Americans have one of the highest prevalence of
T2D in the USA but little is known about their genetic risks.
This review summarizes the findings of genetic regions and
loci associated with T2D and related glycemic traits using
linkage, admixture, and association approaches in populations
of African ancestry. In particular, findings from genome-wide
association and exome chip studies suggest the presence of
both ancestry-specific and shared loci for T2D and glycemic
traits. Among the European-identified loci that are transfer-
able to individuals of African ancestry, allelic heterogeneity
as well as differential linkage disequilibrium and risk allele
frequencies pose challenges and opportunities for fine map-
ping and identification of causal variant(s) by trans-ancestry
meta-analysis. More genetic research is needed in African
ancestry populations including the next-generation sequenc-
ing to improve the understanding of genetic architecture of
T2D.
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Introduction
Diabetes is a global health problem affecting 347 million peo-
ple worldwide [1] and is predicted to be the seventh leading
cause of death by 2030 [2]. In the USA, 28.9 million adults
have diabetes and 86 million adults have pre-diabetes, ac-
counting for nearly half of the population. Diabetes
disproportionally affects the minority populations with higher
prevalence in Native Americans (15.9 %), non-Hispanic
blacks (13.2 %), Hispanics (12.8 %), and Asian Americans
(9 %) as compared to non-Hispanic whites (7.6 %) [3].
Among all diabetes cases, about 90 % are classified as having
type 2 diabetes (T2D). T2D is characterized by hyperglycemia
resulting from both pancreatic beta cell dysfunction with de-
creased insulin secretion and insulin resistance at target tis-
sues. T2D susceptibility is strongly influenced by aging, obe-
sity, family history, and ethnicity. In concordance with the
observations in adults, the prevalence of T2D is substantially
higher in children of minority populations than in non-
Hispanic whites (0.034–0.12 % vs. 0.017 %, respectively)
while the reverse trend is observed for type 1 diabetes
(0.035–0.162 % vs. 0.255 %, respectively) [4]. The disparity
of T2D in the minority populations is partly contributed by the
mirroring prevalence of obesity in non-Hispanic blacks
(47.8 %), Hispanics (42.5 %), and non-Hispanic whites
(32.6 %) [5]. In addition, T2D-associated comorbidities in-
cluding kidney disease, retinopathy, and cardiovascular dis-
eases are also highly prevalent in minority populations
[6–12]. Diabetes is a huge burden to public health, with direct
medical and indirect costs totaling $245 billion [3].
T2D and associated complications have been attributed to
behavioral and socio-economic factors [13–15] but are also
influenced by genetic factors as evidenced by strong cluster-
ing of diabetes within families [16–18]. Currently, most ge-
netic research on T2D is being conducted in European
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ancestry populations. Little is known of whether individual
genetic background contributes to racial disparity of T2D in
minority populations. This article will review the genetic re-
search of T2D and respective glycemic traits conducted in
populations of African ancestry and highlight their importance
in understanding the genetic risk factors predispose to T2D.
Linkage Mapping
Several genome-wide linkage studies in families of African
ancestry have been conducted to search for chromosomal re-
gions linked to T2D and glycemic traits. The Africa America
Diabetes Mellitus (AADM) study recruited 343 T2D-affected
sibling pairs fromWest Africa. Evidence of suggestive linkage
for T2D was found on chromosomes 12q, 20q, and 19p, of
which the former two linkage peaks had been reported in other
populations [19]. In addition, four genetic loci at chromo-
somes 10q, 4p, 15q, and 18p were linked to C-peptide con-
centration [20]. The Sea Islands Genetic African American
Registry studied 521 Gullah-speaking African Americans
from 197 families and identified suggestive linkage at chro-
mosomes 14q, 1q, 3q, and several regions at 7p [21]. The
Family Investigation of Nephropathy and Diabetes (FIND)
study included 1004 African Americans from 362 families
and identified significant linkage at chromosome 4q, and sug-
gestive linkage at chromosomes 12q and 22q [22]. The largest
T2D linkage analysis in African Americans was conducted by
the Genetics of Non-Insulin-Dependent Diabetes Mellitus
(GENNID) study and included 1496 individuals from 580
African American families. Significant and suggestive linkage
for T2D was identified on chromosomes 2p, and 13p and 7p,
respectively [23]. Subsequent fine mapping suggested the
presence of multiple susceptibility genes under the linkage
peaks, including strong association at GRB10 on chromosome
7p [24]. It is intriguing that the GRB10 locus was associated
with fasting glucose level in European populations [25] but
showed no evidence of association for T2D in African
Americans [26••]. Collectively, despite the presence of sugges-
tive evidence of linkage at multiple chromosomal regions, none
overlapped among the African ancestry studies, and the causal
genes underlying the linkage peaks, if any, have not been iden-
tified. The lack of strong association of common variants sug-
gests rare variants with strong effect may account for some of
the linkages. The challenge of mapping T2D loci by linkage
highlights the complex genetic architecture of T2D [27].
Genome-Wide Association Mapping
Genome-wide association studies (GWAS) have successfully
identified common variants in thousands of genetic loci asso-
ciated with complex traits in the past decade. The first series of
T2D GWAS conducted in 2007 in populations of European
ancestry identified eight loci at or near TCF7L2, SLC30A8,
HHEX, CDKAL1, CDKN2A/B, IGF2BP2, KCNJ11, and FTO
[28–31]. Subsequently, rapid discovery has been facilitated by
increased density of genotyping arrays, improvement of hap-
lotype reference panels and imputation methods, and most
importantly, increased sample size through international col-
laborations. The DIAbetes Genetics Replication And Meta-
analysis (DIAGRAM) consortium and the Meta-Analyses of
Glucose and Insulin-related traits consortium (MAGIC) con-
ducted large-scale meta-analysis of GWAS for T2D and gly-
cemic traits, respectively, in European ancestry populations.
Up to now, they and others have identified >80 loci associated
with T2D, and >70 loci associated with glycemic traits includ-
ing fasting glucose, fasting insulin, fasting proinsulin, insulin
secretion and insulin resistance measured by homeostatic
model assessment (HOMA), glucose measured at oral glucose
tolerance test, corrected insulin response to glucose, and
HbA1c [32•, 33].
The majority of loci for T2D and glycemic traits have been
identified from European ancestry populations [34, 35]. It is
unclear whether genetic variants and loci identified from
European ancestry populations are transferable to non-
European populations, and if ancestry-specific genetic loci
are present. Early GWAS in non-European populations had
relatively small sample sizes that limit detection of common
genetic variants with moderate effects [36–38]. The first T2D
GWAS in African Americans was reported in 2012 and iden-
tified a novel locus near RND3 and RBM43 from 1994 dis-
covery and 4455 replication/validation samples [39•].
Another GWAS that examined fasting insulin and insulin re-
sistance from the HOMA model in 1497 African American
and West African subjects identified two novel loci at
SC4MOL and TCERG1L [40•] (Table 1).
The Meta-analysis of the Type 2 Diabetes in African
Americans (MEDIA) consortium was formed with the aim
of improving the power of GWAS to identify T2D loci in
African Americans. A similar effort for meta-analysis of
GWAS for glycemic traits is currently underway by the
African American Genetics of Glucose and Insulin
(AAGILE) consortium. The MEDIA consortium has recently
conducted a large-scale meta-analysis of T2D GWAS that
included 23,827 African Americans from 17 GWAS in the
discovery stage, followed by replication in 11,544 African
Americans and 47,117 Europeans [26••]. SNPs from three
established loci (TCF7L2, KCNQ1, and HMGA2) and two
novel loci (HLA-B and INS-IGF2) were significantly associ-
ated with T2D at a genome-wide level (Table 1).
This study highlights the opportunity and challenge of T2D
loci discovery in African American populations. First, the as-
sociated SNPs at the two novel loci either have stronger effect
(HLA-B) or have higher frequency (INS-IGF2) in individuals
of African ancestry than in individuals of European ancestry,
which led to higher study power to detect these associations.
Similar observations also led to the novel discovery of
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KCNQ1, UBE2E2, and C2CD4A-C2CD4B in East Asians
[41–43] and SLC16A11 in Mexicans and Latin Americans
[38]. It is intriguing that several of these variants confer T2D
risk to specific populations only, as they are monomorphic or
very rare in others.
Second, early GWAS arrays have substantially lower
genome-wide coverage of common SNPs for African ancestry
(28–49 %) compared to European ancestry populations (75–
86%) [44], leading to inefficient imputation and loss of power
to detect association. Indeed, the HapMap imputed SNPs for
the MEDIA study only cover 43.3 % of common SNPs in the
1000 Genomes ASW population at r2≥0.8, which partly ex-
plains the low number of genome-wide significant loci found
in African Americans [26••]. Newer genotyping arrays that are
population-specific or targeted to multiple ethnicities, such as
the Axiom Genome-Wide PanAFR Array and the Infinium
Multi-Ethnic Genotyping Array, have higher coverage for
African ancestry populations, and thus will likely improve
the power to identify African ancestry-associated variants.
Improvement in the genome-wide coverage and haplotypes
of diverse populations in reference panels for imputation such
as the 1000 Genomes Project [45] and the Haplotype
Reference consortium (http://www.haplotype-reference-
consortium.org/) will also improve imputation quality,
especially for identification of low frequency disease variants.
Transferability and Fine Mapping of Established T2D
Loci
Given the large number of loci associated with T2D and gly-
cemic traits in European ancestry populations, it is of interest
to test if these loci are also implicated in populations of dif-
ferent ancestry. Several strategies, including exact replication,
local replication, and local transferability, have been used
[44]. In this review, exact replication refers to testing associa-
tion at the exact SNP identified from the discovery population
with the same direction of effect. Local replication refers to
testing association of all proxy SNPs in linkage disequilibrium
(LD) with the original reported SNP, including itself. Local
transferability refers to testing association of all SNPs, regard-
less of LD, in a region around the original reported SNP,
bounded by a fixed distance or the most extended SNPs in
LD [44]. Significant association is defined as P<0.05 in exact
replication. In local replication and local transferability, sig-
nificant association is defined as P<0.05 after adjustment for
the number of effective SNPs in each locus. While an associ-
ation in the local replication analysis implies that the causal
variant(s) resides on the same haplotype between the discov-
ery and follow up studies, the presence of association in the
local transferability analysis may indicate either an indepen-
dent new signal or represent the same association signal as in
the original discovery study.
Early studies in African Americans and other populations
focused on exact replication of the reported index SNPs. A
study of 4045 African Americans demonstrated nominal rep-
lication of 5 out of 17 T2D index SNPs, with the strongest
association observed at rs7903146 in TCF7L2 (OR=1.38, P=
1.25×10−8) [46]. Resequencing suggests that rs7903146 is the
causal variant in this region [47], and this SNP remains the
strongest association with T2D in African Americans [26••].
In the multi-ethnic study from the Population Architecture
using Genomics and Epidemiology (PAGE) consortium,
among 20 index SNPs from 18 established T2D loci, the di-
rection of associations are largely consistent across popula-
tions of European American, African American, Hispanic,
East Asian, American Indian, and Native Hawaiian ancestry
[48]. However, risk allele frequencies of the index SNPs are
substantially different at some loci, and only 7 index SNPswere
nominally associated with T2D in 11,599 African Americans.
Using genetic risk score to combine the effects of risk alleles of
these index SNPs did not demonstrate conclusive association
with T2D in African Americans [46, 49, 50].
Exact replication may produce false negative results when
replicating in another population with different LD structure,
Table 1 Genome-wide significant loci associated with T2D and glycemic traits in African ancestry populations





T2D RND3-RBM43 rs7560163 0.75 (0.67–0.84) 965/1029 2167/2288 [39]
T2D TCF7L2 rs7903146 1.36 (1.32–1.4) 8284/15,543 14,191/44,470 [26••]
T2D KCNQ1 rs231356 1.09 (1.06–1.13) 8284/15,543 14,191/44,470 [26••]
T2D KCNQ1 rs2283228 1.19 (1.13–1.24) 8284/15,543 14,191/44,470 [26••]
T2D HMGA2 rs343092 1.14 (1.1–1.19) 8284/15,543 14,191/44,470 [26••]
T2D HLA-B rs2244020 1.09 (1.06–1.13) 8284/15,543 14,191/44,470 [26••]
T2D INS-IGF2 rs3842770 1.14 (1.09–1.19) 8284/15,543 6061/5483 [26••]
Fasting insulin SC4MOL rs17046216 0.18 (0.12–0.24) 927 570 [40•]
Fasting insulin TCERG1L rs7077836 0.28 (0.18–0.38) 927 570 [40•]
a Odds ratio are presented for T2D and effect size are presented for glycemic traits under additive model
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particularly for African Americans given their greater genetic
diversity and lower level of LD [51]. In a local transferability
study of 7071 African Americans, 7 index SNPs from 40 T2D
loci were replicated [52•]. Significant local transferability was
observed for four loci, but only two of the local significant
SNPs were in LD with the index SNPs from Europeans.
Among 65 established T2D loci reported by the DIAGRAM
consortium, 34 index SNPs were genome-wide significant in
Europeans [34]. By examining these 34 loci in the MEDIA
consortium, exact replication only yielded 17 significant
SNPs (Fig. 1a) whereas local transferability yielded 25 signif-
icant loci in African Americans (Fig. 1b) [26••]. In addition,
among the lead SNPs at these 25 significant loci, only 12 lead
SNPs were moderately correlated (r2≥0.3 in HapMap CEU
population) with the European index SNPs. The results of this
and other studies suggest that many, but not all, of the
established T2D loci are shared across ancestries. The low level
of exact replication is partly due to differential LD structure
between Europeans and African Americans, where causal var-
iant(s) may lie on different haplotypes. The possible presence
of different or multiple causal variant(s) in different populations
may account for the lack of correlation for some of the index
SNPs between populations, although false positives in local
transferability analysis could not be excluded.
Among genetic loci that are shared across different popu-
lations and display differential LD, the African American
GWAS provides a great opportunity to finemap the associated
regions through trans-ancestry meta-analysis [53]. While
Europeans tend to have long range LD due to population
bottleneck that facilitates gene discovery, it is difficult to dis-
tinguish which of the associated variants in high LD may be
causal. Recent trans-ancestry meta-analysis of T2D GWAS in
110,452 individuals of European, East Asian, South Asian,
Mexican, and Mexican American ancestry improved fine
mapping resolution of European GWAS. Assuming a locus
harbors a single causal variant, the number of SNPs and size
of genomic interval that the causal variant has 99 % probabil-
ity being included in the 99 % credible set was reduced in 9 of
10 established T2D loci in trans-ancestry meta-analysis [54••].
Future studies that include African Americans in trans-
ancestry meta-analysis will maximize the resolution of fine
mapping since African Americans tend to have lower and
differential LD compared to other populations.
Transferability and Fine Mapping of Established
Glycemic Loci and their Associations with T2D in African
Americans
As for glycemic traits, the PAGE consortium examined 7526
AfricanAmericans for exact replication of 9 fasting glucose and
2 fasting insulin index SNPs identified from European ancestry
GWAS. Only three SNPs at the MNTR1B and TCF7L2 loci
were nominally associated with fasting glucose in African
Americans [55]. Among 927 African Americans from the
Howard University Family Study (HUFS), 3 of the 12 fasting
glucose index SNPs at the DGKB, SLC30A8, and TCF7L2 loci
identified from the MAGIC consortium were directly replicat-
ed. Further local replication demonstrated additional associa-
tions at the G6PC2, GCKR, MNTR1B, and IRS1 loci [56].
The Candidate Gene Association Resource (CARe) study
examined 5984African Americans in 16 fasting glucose and 2
fasting insulin loci reported by the MAGIC consortium [57•].
Exact replication yielded three SNPs at GCK, MTNR1B, and
G6PC2 for association with fasting glucose (Fig. 2a), with the
strongest association observed at rs10830963 of theMTNR1B
locus (P=8.51×10−9). Local transferability demonstrated as-
sociation of GCK, MTNR1B, and FADS1 for fasting glucose,
and GCKR for fasting insulin (Fig. 2b). Examination of the
Fig. 1 Replication and transferability of 34 genome-wide significant
T2D loci in Europeans (EA) from the DIAGRAM consortium to
African Americans (AA) from the MEDIA consortium. a odds ratio
(OR) of risk alleles of index SNPs. b OR of index SNPs from
Europeans and locus-wide lead SNPs from African Americans. Red
symbols represent significant association at P<0.05 in replication and
Plocus<0.05 in transferability analyses. Blue symbols represent
insignificant associations
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four lead locus-significant SNPs revealed only nominal asso-
ciation of the risk G allele of rs10830963 atMTNR1B for T2D
risk in the MEDIA consortium (OR=1.11, P=0.02) [26••].
Taken together, the low level of transferability of glycemic
trait loci between populations of European and African ances-
try is consistent with findings for T2D. The lack of overlap of
loci and correlation of their respective effect sizes between
T2D and glycemic trait loci are also consistent with findings
from the DIAGRAM and MAGIC consortia, which suggests
that genes influencing normal physiological levels of metabol-
ic traits may be different from those leading to pathological
levels of metabolic traits that define T2D [58]. Given the sam-
ple size of the CARe study has limited power, the current
effort of meta-analysis and fine mapping of glycemic traits
from GWAS of African ancestry at the AAGILE consortium
will provide a clearer picture for these questions.
Association of Low Frequency Variants with T2D
and Glycemic Traits
The development of exome chip derived from large-scale ex-
ome sequence studies allows cost-effective genotyping of
∼250,000 variants, primarily low frequency protein-altering
variants, in large number of samples. However, the coverage
of low frequency coding variants are lower in non-European
populations given the discovery of coding variants are primar-
ily from European ancestry individuals. The Cohorts for Heart
and Aging Research in Genomic Epidemiology (CHARGE)
T2D-Glycemia Exome consortium examined 60,564 non-
diabetic subjects of European (84 %) and African (16 %) an-
cestry, and 98,368 T2D cases and controls of European
(75 %), African (14 %), Asian (5 %), and Hispanic (6 %)
ancestry using exome chips [59••]. In the combined ancestry
analyses, a low frequency nonsynonymous SNP at GLP1R
was associated with improved glycemic traits and lower
T2D risk. Gene-based analysis of low frequency protein-
altering variants revealed association of G6PC2 with fasting
glucose level. The associations at GLP1R and G6PC2 were
likely contributed predominantly, if not all, by the European
data in the CHARGE consortium, as the same associations
were also observed in Europeans by the Type 2 Diabetes
Genetic Exploration by Next-generation sequencing in
multi-Ethnic Samples (T2D-GENES) and Genetics of Type
2 Diabetes (GoT2D) consortia [60••]. On the other hand, anal-
ysis of established T2D loci in individuals of African ancestry
revealed strong protective or risk effects on T2D for the minor
alleles of low frequency nonsynonymous variants at
SLC30A8, ARAP1, and GIPR (OR=0.45–1.69, P<1×10−4).
These data support the contribution of low frequency variants
and their allelic and locus heterogeneity on T2D risk and
modulation of glycemic levels.
Admixture Mapping
The African American population is admixed, with an average
of 80 % African and 20 % European ancestry, although level
of admixture varies considerably among individuals [61].
Given the higher prevalence of T2D in African Americans
than in Europeans, it is hypothesized that some disease-
associated genetic variants may differ substantially between
the ancestral populations of African Americans and contribute
to the disparity of disease prevalence. Admixture mapping
typically uses ancestry informative markers to identify chro-
mosomal regions containing risk alleles of a disease locus that
are overrepresented in the ancestry with higher disease prev-
alence [62] (e.g., African ancestry for T2D). Admixture map-
ping has more power than linkage mapping when detecting
disease-associated variants with highly differentiated
Fig. 2 Replication and transferability of 18 fasting glucose (FG) and
fasting insulin (FI) loci in Europeans (EA) from the MAGIC
consortium to African Americans (AA) from the CARe study. a Effect
size of risk alleles of index SNPs. b Effect size of index SNPs from
Europeans and locus-wide lead SNPs from African Americans. Red
symbols represent significant association at P<0.05 in replication and
Slocus <0.05 in transferability analyses. Blue symbols represent
insignificant associations
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frequency across ancestries. In the study by Cheng et al. [63],
African ancestry was associated with 33 % increased risk of
developing T2D between individuals with the highest and
lowest tertiles of African ancestry. Subsequent admixture
mapping in 7021 African Americans T2D cases and controls
identified two potential loci at chromosomes 12p and 13q.
However, another study did not show significant difference
in the distribution of African ancestry between T2D cases and
controls, while admixture mapping identified a potential sig-
nal on chromosome 11q [64]. Whether there is enrichment of
risk alleles at disease loci in African ancestral haplotypes that
may influence genetic risk for T2D remains to be determined.
Population Differentiation and Selection at T2D Loci
Several population genetics studies have attempted to under-
stand if population differentiation of T2D risk alleles is present
and identify the respective factors that may contribute to T2D
disparity across populations. While the risk alleles and their
effect sizes are mostly consistent across different populations,
strong differentiation of some T2D risk alleles and their loci
have been reported, especially in the sub-Saharan African and
East Asian populations [65, 66], despite not all loci demon-
strating population differentiation [67•]. Most T2D risk alleles
tend to show decreasing frequency along with human migra-
tion out of Africa, such that the African and East Asian pop-
ulations carry the highest and lowest T2D genetic risk scores,
respectively [66]. Genetic drift, migration history, and natural
selection have been proposed to explain these differences [65,
66, 68]. The thrifty gene hypothesis proposed by Neel [69]
suggests that genetic variants that promote efficient energy
absorption and storage at time of feast and famine during the
hunter-gatherer environment in the past leads to excess energy
storage and increase risk for T2D in modern times with sed-
entary lifestyle and abundant food supply. However, recent
positive selection was found on both risk and protective alleles
at some loci [65, 67•], which is inconsistent with the thrifty
gene hypothesis. There are, however, major drawbacks that
may bias the interpretation of these studies. Most of the risk
alleles and index SNPs are derived from European ancestry
GWAS where causal variants are not directly tested. In addi-
tion, not all T2D loci found in Europeans are transferable to all
populations. The identification of causal variants, both com-
mon and rare, through trans-ancestry fine mapping and se-
quencing in different populations will help to understand the
genetic contribution to the disparity of T2D prevalence.
Conclusions
Mapping genes for T2D and glycemic traits in African
Americans has been challenging given the admixed nature
of the population and the low degree of LD across the
genome. Large-scale GWAS are ongoing and have shown
some success in identifying novel genetic variants and dem-
onstrated that substantial numbers of T2D-related loci are
shared between Europeans and African Americans. The dif-
ferential and lower level of LD in African Americans will
likely greatly improve the fine mapping of causal variants in
ongoing trans-ancestry meta-analysis efforts. On the other
hand, far fewer genome-wide significant loci have been iden-
tified in GWAS of African Americans as compared to
Europeans which could not be solely explained by the smaller
sample size in African Americans, and a large proportion of
missing heritability remains to be explained. Studies using
next-generation sequencing in the genome, exome, and
targeted regions are emerging in different populations includ-
ing those of African ancestry. In particular, whole genome
sequencing enables the generation of better reference panels
to improve imputation quality and thus improve power of
subsequent association studies. Additional large-scale
genotyping of variants identified from sequencing studies is
necessary to delineate the effect of low frequency and rare
variants on T2D risk. Evidence of population differentiation
and selection pressure on some T2D-related loci has been
observed. Identification of loci and the respective causal var-
iants in individual populations will be necessary to provide
better insights as to whether genetic risks contribute to T2D
disparity among different populations. Taken together, there is
an urgent need for more genetic research in African ancestry
populations to improve the understanding of genetic architec-
ture of T2D and related traits.
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